The Goodpasture cross county runner who collapsed Oct. 16 during a recreational run died of natural causes, according to an ...

New research reveals millions of Americans face significant heart failure risks, with age and blood pressure emerging as ...

Alleviant Medical, Inc., a privately held medical device company developing a no-implant atrial shunt for heart failure, ...

Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing ...

Tufts Medical Center is celebrating the completion of more adult heart transplants during 2024 than in any prior year.

Alleviant Medical announced today that it brought in $90 million to fund the second pivotal trial of its atrial shunt ...

India's top Army hospital has successfully performed the country's first government-based LVAD implantation, akin to a ...

Gilde Healthcare leads new round of financing as Alleviant expands focus to the full spectrum of chronic heart failure Alleviant Medical, Inc., a privately held medical device company developing a ...

The procedure was successfully performed at the Army Hospital (Research & Referral) at Delhi Cantonment on a 49-year-old ...

The new approach is designed to create a connection between the left and right atrial chambers of the heart in a single procedure without leaving an implant behind.

The $90m will be used to launch the second of two pivotal trials examining the company’s therapy for patients living with heart failure.

Idiopathic epilepsy is the most common medical neurologic disorder of dogs and is reported to affect one in every 100 dogs.